|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.470 CNY | +0.94% |
|
+0.94% | -0.31% |
| Market Cap | 4.48B 663M 576M 536M 492M 930M 63.27B 944M 6.32B 2.48B 31.5B 2.49B 2.43B 106B | P/E 2024 |
18.1x | P/E 2025 | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.69B 547M 475M 442M 406M 767M 52.19B 779M 5.21B 2.05B 25.98B 2.05B 2.01B 87.12B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.65x |
| Free-Float |
79.86% | Yield 2024 |
4.93% | Yield 2025 | 5.39% |
| 1 day | +0.94% | ||
| 1 week | +0.94% | ||
| 1 month | +9.11% | ||
| 3 months | -8.62% | ||
| 6 months | -5.41% | ||
| Current year | -0.31% |
| 1 week | 6.33 |  | 6.62 |
| 1 month | 6 | | 6.85 |
| Current year | 5.6 | | 7.19 |
| 1 year | 5.6 | | 8.68 |
| 3 years | 4.94 | | 9 |
| 5 years | 4.94 | | 11.9 |
| 10 years | 4.5 | | 11.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 42 | 2019-04-22 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 54 | 2017-05-16 |
Peng Bo Ren
PRN | Corporate Officer/Principal | 53 | 2007-03-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Wu Xian Ren
CHM | Chairman | 66 | 2005-05-25 |
Peng Bo Ren
BRD | Director/Board Member | 53 | 2014-05-14 |
Wei Ren
BRD | Director/Board Member | 42 | 2019-04-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.94% | +0.94% | -18.62% | -5.69% | 663M | |
| -0.53% | +2.54% | +22.14% | +74.08% | 50.03B | |
| -1.81% | -0.49% | +48.83% | +107.71% | 36.6B | |
| +0.46% | +4.44% | -1.97% | +25.02% | 12.47B | |
| +1.05% | +1.63% | +18.73% | +77.76% | 11.77B | |
| -1.33% | -0.76% | +30.73% | +127.63% | 9.04B | |
| -2.99% | -2.09% | +45.28% | -11.87% | 7.03B | |
| +0.51% | +1.46% | +13.46% | +32.06% | 6.79B | |
| +1.99% | +1.91% | +8.03% | +183.42% | 6.6B | |
| +0.39% | +3.39% | -35.25% | +4.49% | 5.49B | |
| Average | -0.13% | +0.75% | +13.14% | +61.46% | 14.65B | |
| Weighted average by Cap. | -0.60% | +1.26% | +24.75% | +77.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.69B 398M 346M 322M 295M 558M 37.96B 566M 3.79B 1.49B 18.9B 1.49B 1.46B 63.37B | 2.24B 332M 288M 268M 246M 465M 31.66B 472M 3.16B 1.24B 15.76B 1.25B 1.22B 52.85B |
| Net income | 243M 35.93M 31.23M 29.07M 26.69M 50.4M 3.43B 51.18M 343M 134M 1.71B 135M 132M 5.73B | 320M 47.38M 41.18M 38.33M 35.19M 66.46M 4.52B 67.49M 452M 177M 2.25B 178M 174M 7.55B |
| Net Debt | -483M -71.49M -62.15M -57.84M -53.11M -100M -6.82B -102M -682M -268M -3.4B -268M -263M -11.39B | -784M -116M -101M -93.96M -86.26M -163M -11.08B -165M -1.11B -435M -5.52B -436M -427M -18.5B |
Employees
3,415
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | CN¥6.470 | +0.94% | 16,771,669 |
| 26-07-30 | CN¥6.410 | -1.69% | 16,237,907 |
| 26-07-29 | CN¥6.520 | +0.46% | 12,455,743 |
| 26-07-28 | CN¥6.490 | -0.92% | 10,317,443 |
| 26-07-27 | CN¥6.550 | +2.18% | 13,644,300 |
- Stock Market
- Stocks
- 600351 Stock
Select your edition
All financial news and data tailored to specific country editions
